Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IONIC RARE EARTHS LIMITED Director's Dealing 2017

Dec 18, 2017

65151_rns_2017-12-18_7de2567f-87b6-4645-834e-8190be2c3265.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Name of entity ORO VERDE LIMITED ABN 84 083 646 477

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director MR ANTHONY ROVIRA
Date of last notice 7 November 2017

Part 1 - Change of director’s relevant interests in securities

Direct or indirect interest Direct
Nature of indirect interest Mr Rovira is a director and shareholder of Rovira
(including registered holder) Geoservices Pty Ltd
Date of change 15 December 2017
No. of securities held prior to change a) Direct
31,592,016 fully paid ordinary shares
22,000,000 options exercisable at $0.05 each
b) Indirect
10,000 fully paid shares
Class Options exercisable at $0.013,expire 30 Nov. 2020
Number acquired 10,000,000
Number disposed -
Value/Consideration -
No. of securities held after change a) Direct
31,592,016 fully paid ordinary shares
22,000,000 options exercisable at $0.05 each
10,000,000 options exercisable at $0.013 each
b) Indirect
10,000 fully paid shares
Nature of changes Director Options as approved at the 22 November
2017 AGM.

Part 2 – Change of director’s interests in contracts

NIL

Part 3 – Closed period

Part 2 – Change of director’s interests in contractsNILPart 3 – Closed period
Were the interests in the securities or contracts detailed No
above traded during a closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade N/A
to proceed during this period?
If prior written clearance was provided, on what date was this N/A
provided?

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Name of entity ORO VERDE LIMITED ABN 84 083 646 477

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR BRADFORD FARRELL
Date of last notice 7 November 2017

Part 1 - Change of director’s relevant interests in securities

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder) Held by Companies of which Dr Farrell is both a directorand shareholder
Date of change 15 December 2017
No. of securities held prior to change 50,851,281 fully paid shares
Class Options exercisable at $0.013, expire 30 Nov. 2020
Number acquired 10,000,000
Number disposed -
Value/Consideration -
No. of securities held after change 50,851,281 fully paid shares10,000,000 Options exercisable at$0.013
Nature of changes Director Options as approved at the 22 November 2017AGM.

Part 2 – Change of director’s interests in contracts

NIL

Part 3 – Closed period

Part 3 – Closed period
Were the interests in the securities or contracts detailedabove traded during a closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Name of entity ORO VERDE LIMITED

ABN 84 083 646 477

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director MR BRETT DICKSON
Date of last notice 7 November 2017

Part 1 - Change of director’s relevant interests in securities

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder) Held by the Dickson Superannuation Fund
Date of change 15 December 2017
No. of securities held prior to change a) Direct1,045,330 fully paid shares11,000,000 options exercisable at $0.05 eachb) Indirect14,375,000 fully paid shares11,000,000 options exercisable at $0.05 each
Class Options exercisable at $0.013, expire 30 Nov. 2020
Number acquired 10,000,000
Number disposed -
Value/Consideration -
No. of securities held after change b) Direct1,045,330 fully paid shares11,000,000 options exercisable at $0.05 each5,000,000 Options exercisable at $0.013 eachb) Indirect14,375,000 fully paid shares11,000,000 options exercisable at $0.05 each5,000,000 Options exercisable at $0.013 each
Nature of changes Director Options as approved at the 22 November 2017AGM.

Part 2 – Change of director’s interests in contracts

NIL

Part 3 – Closed period

Part 3 – Closed period
Were the interests in the securities or contracts detailedabove traded during a closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Name of entity ORO VERDE LIMITED ABN 84 083 646 477

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR WOLF GERHARD MARTINICK
Date of last notice 7 November 2017

Part 1 - Change of director’s relevant interests in securities

Direct or indirect interest Direct&Indirect
Nature of indirect interest(including registered holder) Dr Martinick is a director of Martinick Investments PtyLtd and a beneficiary of the Martinick SuperannuationFund of which Martinick Investments is a trustee
Date of change 15 December 2017
No. of securities held prior to change Direct – 9,481,154Indirect – 44,875,000 fully paid shares
Class Options exercisable at $0.013, expire 30 Nov. 2020
Number acquired 10,000,000
Number disposed -
Value/Consideration -
No. Of securities held after change Direct – 9,481,154 fully paid sharesIndirect – 44,875,000 fully paid sharesDirect – 10,000,000 Options exercisable at $0.013,expire 30 Nov. 2020
Nature of changes Director Options as approved at the 22 November 2017AGM.

Part 2 – Change of director’s interests in contracts

NIL

Part 3 – Closed period

NILPart 3 – Closed period
Were the interests in the securities or contracts detailedabove traded during a closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period? N/A
If prior written clearance was provided, on what date was thisprovided? N/A